Definium Therapeutics Inc. Common Shares vs Patterson-UTI Energy Inc. Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Patterson-UTI Energy Inc. Common Stock trades at $11.45 (market cap $4.28B). The key difference: Definium Therapeutics Inc. Common Shares and Patterson-UTI Energy Inc. Common Stock are close in size by market cap, and Patterson-UTI Energy Inc. Common Stock pays a 3.56% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Patterson-UTI Energy Inc. Common Stock for 0 Days on average.
| DFTX | PTEN | |
|---|---|---|
Market Cap | $4.71B | $4.28B |
Volume | 1,966,636 | 5,046,340 |
Sector | Health | Energy |
52-Week High | $48.45 | $13.15 |
52-Week Low | $10.68 | $5.37 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.67B | $5.37B |
Dividend Yield | — | 3.56% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Patterson-UTI Energy provides drilling, completion, and other oilfield services for oil and gas producers in the United States.
Read more on PTEN →